An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptor.
The phospholipase A2 receptor (PLA2R) was recently discovered as a target autoantigen in patients with idiopathic membranous nephropathy (IMN). Published evidence suggests that the autoantibodies directed towards a conformation dependent epitope are currently effectively detected by a cell based ass...
Main Authors: | Astrid Behnert, Marvin J Fritzler, Beina Teng, Meifeng Zhang, Frank Bollig, Hermann Haller, Andrej Skoberne, Michael Mahler, Mario Schiffer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3639255?pdf=render |
Similar Items
-
Antiphospholipase A2 Receptor Autoantibodies: A Comparison of Three Different Immunoassays for the Diagnosis of Idiopathic Membranous Nephropathy
by: Astrid Behnert, et al.
Published: (2014-01-01) -
Anti-phospholipase A2 receptor antibodies in membranous nephropathy
by: Sangho Lee
Published: (2018-09-01) -
Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in Primary Membranous Nephropathy
by: Cornelia Dähnrich, et al.
Published: (2020-02-01) -
A New Chemiluminescence Immunoassay for Phospholipase A2 Receptor 1 Autoantibodies Allows Early Identification of Autoantibody Recurrence in Patients With Membranous Nephropathy
by: Elion Hoxha, et al.
Published: (2021-04-01) -
The significance of anti-phospholipase receptor antibodies in a patient with membranous nephropathy
by: Jayaprakash R Dasari, et al.
Published: (2020-01-01)